Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences in HIV risk factors between South African adolescents and adult women and their association with sexually transmitted infections.
Mkhize P, Mehou-Loko C, Maphumulo N, Radzey N, Abrahams AG, Sibeko S, Harryparsad R, Manhanzva M, Meyer B, Radebe P, Liebenberg LJP, Ngcapu S, Ahmed N, Busakwe F, Mqaba N, Archary D, Sivro A, Samsunder N, Potloane D, Horsnell W, Jordan C, Abdool Karim Q, Bekker LG, Passmore JA, Jaspan H, Humphries H, Masson L. Mkhize P, et al. Among authors: radebe p. Sex Transm Infect. 2024 Dec 4:sextrans-2024-056260. doi: 10.1136/sextrans-2024-056260. Online ahead of print. Sex Transm Infect. 2024. PMID: 39632075 Free article.
High burden of human papillomavirus and premalignant cervical lesions among women starting HIV treatment in KwaZulu-Natal, South Africa.
Naicker N, Osman F, Naidoo K, Bodley N, Mbambo N, Madlala S, Mhlongo T, Mbatha N, Maphumulo A, Munatsi P, Radebe P, Liebenberg L, Dorward J, Drain PK, Garrett N. Naicker N, et al. Among authors: radebe p. Sex Transm Infect. 2024 Nov 18:sextrans-2024-056129. doi: 10.1136/sextrans-2024-056129. Online ahead of print. Sex Transm Infect. 2024. PMID: 39557497
Machine Learning to Predict Interim Response in Pediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests.
Geel JA, Hramyka A, du Plessis J, Goga Y, Van Zyl A, Hendricks MG, Naidoo T, Mathew R, Louw L, Carr A, Neethling B, Schickerling TM, Omar F, Du Plessis L, Madzhia E, Netshituni V, Eyal K, Ngcana TVZ, Kelsey T, Ballott DE, Metzger ML; South African Children's Cancer Study Group. Geel JA, et al. JCO Glob Oncol. 2024 Oct;10:e2300435. doi: 10.1200/GO.23.00435. Epub 2024 Oct 24. JCO Glob Oncol. 2024. PMID: 39447089 Free PMC article.
Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT).
Ramboarina S, Crucitti T, Gill K, Bekker LG, Harding-Esch EM, van de Wijgert JHHM, Huynh BT, Fortas C, Harimanana A, Mayouya Gamana T, Randremanana RV, Mangahasimbola R, Dziva Chikwari C, Kranzer K, Mackworth-Young CRS, Bernays S, Thomas N, Anderson D, Tanko FR, Manhanzva M, Lurie M, Khumalo F, Sinanovic E, Honda A, Pidwell T, Francis SC, Masson L, Passmore JA; GIFT study group. Ramboarina S, et al. BMJ Open. 2024 May 1;14(5):e084918. doi: 10.1136/bmjopen-2024-084918. BMJ Open. 2024. PMID: 38692732 Free PMC article.
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial.
Mahomed S, Garrett N, Potloane D, Sikazwe IT, Capparelli E, Harkoo I, Gengiah TN, Zuma NY, Osman F, Mansoor L, Archary D, Myeni N, Radebe P, Samsunder N, Doria-Rose N, Carlton K, Gama L, Koup RA, Narpala S, Serebryannyy L, Moore P, Williamson C, Pozzetto B, Hankins C, Morris L, Karim QA, Abdool Karim S. Mahomed S, et al. Among authors: radebe p. BMJ Open. 2023 Aug 28;13(8):e076843. doi: 10.1136/bmjopen-2023-076843. BMJ Open. 2023. PMID: 37640457 Free PMC article.
CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women.
Gengiah TN, Abdool Karim Q, Harkoo I, Mansoor L, Zuma NY, Radebe P, Samsunder N, Baxter C, Maharaj B, Baum MM, Moss JA, Pozzetto B, Hankins C, Abdool Karim S. Gengiah TN, et al. Among authors: radebe p. BMJ Open. 2022 Jan 6;12(1):e052880. doi: 10.1136/bmjopen-2021-052880. BMJ Open. 2022. PMID: 34992111 Free PMC article.